Vanguard Group’s Dianthus Therapeutics DNTH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $26.9M | Buy |
|
|||||
|
2025
Q1 | $20.1M | Sell |
|
|||||
|
2024
Q4 | $27.8M | Sell |
|
|||||
|
2024
Q3 | $35.5M | Buy |
|
|||||
|
2024
Q2 | $32.2M | Buy |
|
|||||
|
2024
Q1 | $16.1M | Buy |
|
|||||
|
2023
Q4 | $1.6M | Buy |
|
|||||
|
2023
Q3 | $1.73M | Buy |
|
|||||
|
2023
Q2 | $1.49M | Hold |
|
|||||
|
2023
Q1 | $1.56M | Buy |
|
|||||
|
2022
Q4 | $776K | Buy |
|
|||||
|
2022
Q3 | $2.77M | Buy |
|
|||||
|
2022
Q2 | $2.29M | Buy |
|
|||||
|
2022
Q1 | $5.39M | Sell |
|
|||||
|
2021
Q4 | $8.56M | Sell |
|
|||||
|
2021
Q3 | $15.2M | Buy |
|
|||||
|
2021
Q2 | $15.1M | Buy |
|
|||||
|
2021
Q1 | $16.9M | Buy |
|
|||||
|
2020
Q4 | $10.4M | Buy |
|
|||||
|
2020
Q3 | $8.06M | Buy |
|
|||||
|
2020
Q2 | $8.82M | Buy |
|
|||||
|
2020
Q1 | $5.6M | Buy |
|
|||||
|
2019
Q4 | $13.4M | Sell |
|
|||||
|
2019
Q3 | $9.07M | Sell |
|
|||||
|
2019
Q2 | $13M | Buy |
|
|||||
|
2019
Q1 | $8.3M | Buy |
|
|||||
|
2018
Q4 | $790K | Sell |
|
|||||
|
2018
Q3 | $1.74M | Buy |
|
|||||
|
2018
Q2 | $1.01M | Buy |
|